Intel outlines Arrival of 'Second Wave' of Mobile Solutions in Healthcare

IntelIntel today presents a White Paper by IDC Healthcare Insights about The Second Wave of Clinical Mobility: Strategic Solution Investments for Mobile Point of Care in Western Europe (IDC #HI233679) at the 2012 World of Health IT Conference in Copenhagen.

According to the White Paper today's busy clinicians are demanding instant-on, always-connected mobile point of care solutions and typically use as many as ten different types of device on any given day; access to timely, accurate information and communications can be a matter of life or death.

But the White Paper says, use of mobile solutions to access information is just the tip of the iceberg; the real benefit lies in communication and collaboration in real-time, whenever and wherever the clinician is working. The ability to consult expeditiously with other team members (specialists, pharmacists and nursing staff) allows the clinician to resolve questions without delay, ensuring best patient care and represents actually a 'second wave' in the development of mobile solutions.

Jan Duffy, Research Director of IDC Healthcare Insights EMEA said "the evidence is in - collaborative workflows lead to improved patient care and better treatment outcomes. Collaboration, communication and coordination underpin the future of healthcare delivery."

Mark Blatt, worldwide medical director of Intel said "collaboration is a work style; it requires more than a commitment to using mobile solutions. It requires the right mobile device for the right task, it depends on workflows that are in themselves collaborative, and it must be supported by the right culture and computing model in a secure mobile environment. Clinicians understand these needs, but many healthcare provider organisations seem to be unable to satisfy them."

The report contains a mixture of primary and secondary research leveraging existing studies and resources from IDC Health Insights; these include results from a study of 50 hospitals and their clinical mobility decision makers in North America and Europe.

Other important insights from the report include:

  • Security was ranked as the most important attribute for mobile devices used in healthcare settings by 54% of survey respondents across the globe.
  • Application servers (62%), client/desktop virtualization (50%), and software distribution solutions to manage and support mobile applications (50%) were among the top 3 infrastructure technologies in production and were among the top 5 for future investment.
  • Laptops are the dominant mobile device (84%), but healthcare provider organizations will be increasingly investing in smartphones and tablets in the next 12 to 24 months.
  • Spending on mobile point of care solutions by Western European healthcare providers is expected to grow from $1.4 billion in 2010 to $2.5 billion in 2015, a compound annual growth rate (CAGR) of 11.4%.

The report concludes that the next 10 years represent the second wave of clinical mobility with significant investment in the underlying infrastructure technologies to support the mainstream use of Mobile Point of Care (MPOC) solutions. Increased adoption of EMR/Electronic Health Records and other clinical systems will improve access to electronic health information, thus accelerating the use of mobile devices to deliver care, collaborate with care team members, and engage patients. The effective use of mobile healthcare solutions will enable healthcare organizations to pursue 'Lean Healthcare' and clinical transformation initiatives by removing waste, delay, and rework from the system through improved, real-time communication between care team members and, ultimately, consumers. Finally, MPOC strategies will help to evolve workflows from being centered on the convenience of clinicians to being more patient centric and thus more focused on improving the patient experience, quality of care, and patient safety.

Related news articles:

About Intel
Intel (NASDAQ: INTC) is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world's computing devices.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...